Includion of young adolescents in policy development for new tuberculosis vaccines
Reviews the inclusion of young adolescents aged 9-14 years in policy development for new TB vaccines, including the potential benefits of adolescent vaccination, evidence requirements, trial design, implementation considerations, and integration with existing adolescent vaccination programmes
TB vaccine theme
Project details
Country
Timeline
Target group
Type of protection of vaccine
Type of research
Partners involved
Africa Health Research Institute, Amsterdam UMC, Aurum institute, Barinthus Bio, Boston University, Centro de Investigação em Saúde de Manhiça, John’s Hopkins University, LSHTM, McGill University, Pediatric TB Contact Studies Consortium, South African Tuberculosis Vaccine Initiative, UCL, University of Otago, University of Washington